RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...

Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $73.00. The ...

CVS Health plans to shed enrollment by more than 1 million members this year, mostly in Medicare Advantage and individual ...

CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met ...

Explore the latest updates from Wall Street as U.S. stocks slip due to rising inflation rates affecting consumers' costs.

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street.

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.